Ministerio de Ciencia, Innovación y Universidades (España), European Commission, Agencia Estatal de Investigación (España), Garcés-Garcés, Jose, Sánchez-Martos, Miguel, Martínez-Navarrete, Gema, Redrado, Marta, Fernández-Moreira, Vanesa, Fernández-Jover, Eduardo, Gimeno, M. Concepción, Sastre-Santos, Ángela, Fernández-Lázaro, Fernando, Ministerio de Ciencia, Innovación y Universidades (España), European Commission, Agencia Estatal de Investigación (España), Garcés-Garcés, Jose, Sánchez-Martos, Miguel, Martínez-Navarrete, Gema, Redrado, Marta, Fernández-Moreira, Vanesa, Fernández-Jover, Eduardo, Gimeno, M. Concepción, Sastre-Santos, Ángela, and Fernández-Lázaro, Fernando
Perylenediimes (PDIs) are very interesting compounds due to their outstanding electrooptical properties, high fluorescence quantum yields, and huge versatility in their synthetic chemistry. Although PDIs are mainly used in optoelectronic applications, the number of biological studies using PDIs has been growing in the last few years. Here, we report on the synthesis and biological studies of two new families of PDIs as phototherapeutic agents. (Figure 1: a) Imidazolium-PDI, b) [AgPy2(PPh3)]-PDI). Thus, we have prepared water-soluble PDIs based on imidazolium salts as photosensitizes to generate singlet oxygen (1O2), which plays a key role in photodynamic therapy. Internalization and cytotoxicity assays were carried out in HeLa and SHSY5Y human neuroblastoma cells lines. On the other hand, taking advantage of the medicinal potential of some metals, we have synthesized new PDIs linked to silver and copper complexes to study their behavior as metallodrugs. Biological assays were also carried out in HeLa cells line.